Adding toxicology collection to a telehealth program should not mean adding complexity. The goal is to create a seamless, scalable testing workflow that connects the provider, patient, collector, and laboratory, making medication monitoring as easy to manage remotely as the telehealth visit itself. Whether supporting behavioral health, Suboxone/MAT, pain management, or other medication monitoring programs, the process should remove logistical barriers, improve patient compliance, and give providers a reliable path from test order to actionable result.
1. Set Up the Collection Workflow
The first step is establishing the laboratory account and defining how testing fits into the provider’s existing telehealth program. This is a key reason providers choose Acutis. We work alongside your team to seamlessly integrate laboratory testing into your existing processes, rather than requiring you to build new workflows around the laboratory. This includes determining who orders testing, how patients are scheduled, what information is collected before the appointment, and how results return to the clinical team. A clear workflow helps keep testing aligned with the patient’s broader treatment plan.
2. Connect and Verify the Patient
With Acutis telehealth collection, patients join a secure video session using a phone, tablet, or computer. A certified collector verifies the patient’s identity, explains the process, and guides them through the observed specimen collection. This allows toxicology collection to happen remotely rather than requiring every patient to visit a collection site.
The Acutis at-home testing experience gives patients a simple path to connect with a certified collector and complete the remote collection process.
3. Complete Collection and Laboratory Testing
Once the observed collection is completed, the specimen moves into the laboratory workflow for testing and reporting. The process is designed to connect remote collection with laboratory testing while maintaining privacy, documentation, and continuity of care. Acutis describes its model as remote, observed toxicology collection connecting treatment centers with certified collectors.
Telehealth visit → testing order → observed collection → laboratory testing → clinical review
For programs managing a Suboxone drug test or other ongoing medication monitoring, this helps keep testing integrated with virtual care.
A Quick Compliance Note
Providers should continue to follow applicable HIPAA, state, prescribing, and controlled-substance telemedicine requirements, including current Ryan Haight Act and DEA telehealth rules.
About Acutis Diagnostics
Acutis Diagnostics supports treatment centres and healthcare providers with secure, observed telehealth toxicology collection. Patients connect virtually with a certified collector who verifies identity and guides the collection process, helping providers extend testing access beyond the traditional collection site. To learn more about setting up a telehealth collection account, contact service@acutis.com OR visit us at https://acutis.com/at-home-testing/
References
- U.S. Department of Health and Human Services / HRSA. Getting Started With Telehealth. Telehealth.HHS.gov. Guidance on HIPAA-compliant technology, privacy, consent, and telehealth implementation.
- U.S. Department of Health and Human Services / HRSA. Planning Your Telehealth Workflow. Telehealth.HHS.gov. Guidance on scheduling, intake, identity verification, documentation, staffing, and workflow design.
- U.S. Department of Health and Human Services / HRSA. Tele-treatment for Substance Use Disorders. Telehealth.HHS.gov. Guidance on telehealth for substance use disorder care, patient monitoring, and treatment workflows.
- Drug Enforcement Administration and U.S. Department of Health and Human Services. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Federal Register. Telemedicine prescribing flexibilities extended through December 31, 2026.
